| Symbol | DGEN |
|---|---|
| Name | DELTAGEN, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 94403 United States CA 1900 South Norfolk Street Suite 105 |
| Telephone | 650-345-7601 |
| Fax | — |
| — | |
| Website | http://www.deltagen.com |
| Incorporation | US |
| Incorporated On | 1997 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | NOT AVAILABLE |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0001034072 |
| Description | Deltagen is a leading provider of drug discovery tools and services to the biopharmaceutical industry. Deltagen offers a suite of programs designed to enhance the efficiency of drug discovery including access to biological models as well as both small-molecule and secreted protein drug targets. In addition, Deltagen offers extensive target validation data in the areas of immunology and metabolic diseases. Deltagens products and programs have been validated by customers and partners such as Eli Lilly & Co., GlaxoSmithKline, Merck & Co., Millennium Pharmaceuticals and Pfizer. Additional info from OTC: |
No news found.